ABT
Abbott Laboratories
NYQ
$86.97
-0.81
(-0.92%)
Neutral · -0.41σ
Quarterly financials
last 5 quarters| Quarter | Revenue | Gross profit | Op income | Net income | Free cash flow | Gross % | Op % | Net % |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $11.16B | $6.27B | $1.34B | $1.08B | $916.0M | 56.2% | 12.0% | 9.6% |
| 2025-12-31 | $11.46B | $6.54B | $2.25B | $1.78B | $2.63B | 57.0% | 19.6% | 15.5% |
| 2025-09-30 | $11.37B | $6.29B | $2.06B | $1.64B | $2.29B | 55.4% | 18.1% | 14.5% |
| 2025-06-30 | $11.14B | $6.29B | $2.05B | $1.78B | $1.54B | 56.4% | 18.4% | 16.0% |
| 2025-03-31 | $10.36B | $5.89B | $1.69B | $1.32B | $933.0M | 56.9% | 16.3% | 12.8% |